Abdelhamid Hamdy
@abdelhamed012
اللهم إنى أسألك اليقين والعافية nephrologist.MRCP
Our review “The Role of Complement in Normal Pregnancy and Preeclampsia” is out! We dive into pathophysiology (in mice & humans), touching on genetics, diagnosis, mgmt, key controversies, & unmet needs. A joy to work with @anuja_java & #JeanRegal frontiersin.org/journals/immun…
Treatment with a novel monoclonal antibody against circulating dipeptidyl peptidase 3 (cDPP3) led to complete reversal of cardiogenic shock in three compassionate use cases in Germany, according to a new research letter. ms.spr.ly/6017s19vd
1/ Hola #Nephtwitter, GN con semilunas es un patrón histológico (proliferación extracapilar) y puede presentarse en diversas enfermedades glomerulares. ➡️ Inflamación continua ⬇️ función renal rápida, lo que se conoce como GNRP. #pednef #IPNAJC
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial | New England Journal of Medicine nejm.org/doi/full/10.10…
Dr. DeFronzo summarized the benefits of GLP-1 analogs. #ATDC2025 Drs. Phillip and Sherr are chairing. GLP-1 and SGLT-2 are mainstay in diabetes management unless otherwise indicated.
Questions and Caveats in Antigen-Defined Membranous Nephropathy (JASN 2025) 🟢One clinical condition ❌one antigen and vice versa doi.org/10.1681/ASN.00…
Should You Stop Taking GLP-1 Drugs Like Ozempic if You Experience Vision Loss? Nation’s Ophthalmologists Respond to European Agency’s New Recommendation aao.org/newsroom/news-…
🧪 New in AJPC: Exploring the link between SGLT2 inhibitors and atherosclerosis—what does the latest evidence reveal? 🔗 ow.ly/spL950WswCf #Cardiology #SGLT2 #Atherosclerosis #PreventiveCardiology #AJPC
Sodium-Glucose Cotransporter 2 Inhibitors and Atherosclerosis
Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate - Liabeuf - 2025 - Fundamental & Clinical Pharmacology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/fc…
Advances in the treatment of systemic lupus erythematosus
🚨 The Takeaway: 🔹TRT = symptom control + fertility loss 🔹GLP-1s = root cause reversal + fertility preservation This isn’t just weight loss. It’s a paradigm shift in how we treat male metabolic hypogonadism.
The effects of semaglutide vs testosterone replacement therapy on functional hypogonadism and sperm quality in men with type 2 diabetes mellitus and obesity | ECE2024 | 26th European Congress of Endocrinology | Endocrine Abstracts endocrine-abstracts.org/ea/0099/ea0099…